Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -426,075 | -309,851 | -312,222 | -251,497 | -78,178 |
| Depreciation Amortization | 386,073 | 224,807 | 124,939 | 111,931 | 7,983 |
| Income taxes - deferred | -546 | -205 | N/A | N/A | N/A |
| Accounts receivable | -4,121 | 9,091 | 7,232 | 4,182 | 6,292 |
| Accounts payable and accrued liabilities | -1,525 | 1,405 | -2,222 | 3,390 | 6,644 |
| Other Working Capital | -2,387 | -40,578 | -48,945 | -31,677 | -25,348 |
| Other Operating Activity | 4,525 | -90,727 | 55,810 | 33,726 | 6,925 |
| Operating Cash Flow | $-44,056 | $-206,058 | $-175,408 | $-129,945 | $-75,682 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 51,623 | 130,192 | 70,337 | 48,059 | -30,257 |
| PPE Investments | -1,389 | -6,188 | -4,571 | -5,358 | -3,879 |
| Purchase Sale Intangibles | -5,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -5,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $45,234 | $124,004 | $65,766 | $42,701 | $-34,136 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -490 | -490 | -490 | -338 |
| Common Stock Issued | 1,959 | 7,703 | 7,703 | 6,891 | 6,891 |
| Other Financing Activity | 0 | -50,200 | 0 | 0 | 0 |
| Financing Cash Flow | $1,959 | $-42,987 | $7,213 | $6,401 | $6,553 |
| Beginning Cash Position | 57,592 | 182,633 | 182,633 | 182,633 | 182,633 |
| End Cash Position | 60,729 | 57,592 | 80,204 | 101,790 | 79,368 |
| Net Cash Flow | $3,137 | $-125,041 | $-102,429 | $-80,843 | $-103,265 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,056 | -206,058 | -175,408 | -129,945 | -75,682 |
| Capital Expenditure | -1,389 | -6,188 | -4,571 | -5,358 | -3,879 |
| Free Cash Flow | -45,445 | -212,246 | -179,979 | -135,303 | -79,561 |